Latest filing published 28 May 2019 for 9 METERS BIOPHARMA, INC., €1,144.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Roy Proujansky: trading record in brief
Roy Proujansky discloses dealings in 9 Meters Biopharma, Inc. to SEC (Form 4). Between 30 November 2018 and 24 May 2019, the trades on record add up to 2 filings.
No open-market sale appears; the market trades are 2 purchases worth €4,376. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2019: 1 purchase and no sales on the market.
Most recently, on 28 May 2019, the filings show an open-market purchase worth €1,144 in 9 Meters Biopharma, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Roy Proujansky
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 shares@ US$1.2826.2% of flowCommon stockSEC:0001551986-19-000056:0Canonical exit: 22 Aug 2019 (T+90)
- 1,400 shares@ US$2.6373.8% of flowCommon stockSEC:0001551986-18-000061:0Canonical exit: 28 Feb 2019 (T+90)
2 of 2 declarations